Technical Analysis for AVDR - Avedro, Inc
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Weak or Absent | N/A | N/A | Down |
| See historical AVDR trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Mar 21 | Fell Below 20 DMA | Bearish | 0.00% |
| Mar 21 | Hot IPO Pullback | Bullish Swing Setup | 0.00% |
| Mar 20 | Overbought Stochastic | Strength | -8.47% |
| Mar 19 | Stochastic Sell Signal | Bearish | -7.91% |
| Mar 19 | Hot IPO Pullback | Bullish Swing Setup | -7.91% |
| Mar 19 | Inside Day | Range Contraction | -7.91% |
| Mar 19 | Overbought Stochastic | Strength | -7.91% |
| Mar 19 | Upper Bollinger Band Touch | Strength | -7.91% |
| Mar 18 | 20 DMA Support | Bullish | -14.23% |
| Mar 18 | New 52 Week Closing High | Bullish | -14.23% |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
Avedro, Inc., an ophthalmic pharmaceutical and medical device company, develops and commercializes products to treat ophthalmic disorders and conditions, primarily associated with corneal weakness. The company's Avedro Corneal Remodeling platform comprises KXL and Mosaic systems, which deliver ultraviolet A or UVA light, and a suite of single-use riboflavin drug formulations. Its Avedro Corneal Remodeling platform treats corneal ectatic disorders and corrects refractive conditions; and KXL system in combination with Photrexa drug formulations used for the treatment of progressive keratoconus and corneal ectasia following refractive surgery. Avedro sells its products through a direct sales force in the United States and through medical device distributors internationally. The company was formerly known as ThermalVision, Inc. and changed its name to Avedro, Inc. in October 2005. Avedro, Inc. was incorporated in 2002 and is headquartered in Waltham, Massachusetts.
Medicine Medical Specialties Surgery Ophthalmology Eye Surgery
Medicine Medical Specialties Surgery Ophthalmology Eye Surgery
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more AVDR news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 14.2 |
| 52 Week Low | 10.75 |
| Average Volume | 176,627 |
| 200-Day Moving Average | 0.0 |
| 50-Day Moving Average | 0.0 |
| 20-Day Moving Average | 12.329 |
| 10-Day Moving Average | 12.683 |
| Average True Range | 1.0562 |
| ADX | 0.0 |
| +DI | 16.2779 |
| -DI | 13.2501 |
| Chandelier Exit (Long, 3 ATRs ) | 11.0314 |
| Chandelier Exit (Short, 3 ATRs ) | 13.9186 |
| Upper Bollinger Band | 13.5855 |
| Lower Bollinger Band | 11.0725 |
| Percent B (%b) | 0.37 |
| BandWidth | 20.382837 |
| MACD Line | 0.2248 |
| MACD Signal Line | 0.147 |
| MACD Histogram | 0.0778 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 13.87 | ||||
| Resistance 3 (R3) | 14.06 | 13.63 | 13.55 | ||
| Resistance 2 (R2) | 13.63 | 13.15 | 13.53 | 13.45 | |
| Resistance 1 (R1) | 12.81 | 12.86 | 12.60 | 12.62 | 13.34 |
| Pivot Point | 12.38 | 12.38 | 12.27 | 12.28 | 12.38 |
| Support 1 (S1) | 11.56 | 11.90 | 11.35 | 11.37 | 10.64 |
| Support 2 (S2) | 11.13 | 11.61 | 11.03 | 10.53 | |
| Support 3 (S3) | 10.31 | 11.13 | 10.43 | ||
| Support 4 (S4) | 10.12 |
